ImmuneSensor Therapeutics

ImmuneSensor Therapeutics is a biotechnology company based in Dallas, Texas, founded in 2019. The company focuses on developing innovative medicines aimed at harnessing the body's innate immune system to treat cancer and autoimmune diseases. ImmuneSensor Therapeutics works on targeting specific pathways to modulate the innate immune response, with the goal of enhancing anticancer immunity through stimulators of interferon gene activators. Additionally, the company seeks to create inhibitors that can suppress overactive autoimmunity. By activating innate immune defenses in response to cytosolic DNA from pathogens, cellular stress, and damaged tumor cells, ImmuneSensor Therapeutics aims to provide effective therapeutic solutions for a variety of diseases.